Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow

New England Journal of Medicine

Volumn 335, Issue 24, 1996, Pages 1806-1810

  Flake, Alan W ^a,f   Roncarolo, Maria Grazia ^c   Puck, Jennifer M ^d   Almeida Porada, Graza ^e   Evans, Mark I ^b   Johnson, Mark P ^b   Abella, Estaban M ^b   Harrison, Duane D ^b   Zanjani, Esmail D ^e  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF NEVADA   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CONCANAVALIN A; DNA; HLA B7 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DNA DETERMINATION; FATHER; FETUS; FETUS SURGERY; FLOW CYTOMETRY; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; MALE; MONONUCLEAR CELL; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; FATHERS; FEMALE; FETAL BLOOD; FETAL DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT, NEWBORN; LINKAGE (GENETICS); LYMPHOCYTE COUNT; MALE; PREGNANCY; PRENATAL DIAGNOSIS; SEVERE COMBINED IMMUNODEFICIENCY; TISSUE DONORS; X CHROMOSOME;

EID: 0029848406     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199612123352404     Document Type: Article

References (41)

1. Fischer A. Severe combined immunodeficiencies, Immunodefic Rev 1992;3:83-100.
2. Primary immunodeficiency diseases: report of a WHO Scientific Group. Clin Exp Immunol 1995;99:Suppl 1:1-24.
3. Puck JM, Stewart CC, Nussbaum RL. Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet 1992;50:742-8.
4. Puck JM, Conley ME, Bailey LC. Refinement of linkage of human severe combined immunodeficiency (SCIDXI) to polymorphic markers in Xq13. Am J Hum Genet 1993;53:176-84.
5. Puck JM, Pepper AE, Bedard PM, Laframboise R. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency. J Clin Invest 1995; 95:895-9.
6. Bacchetta R, Bigler M, Touraine IL, et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179:493-502.
7. de Wynter E, Coutinho L, Pei X, et al. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells (Dayt) 1995;13:524-32.
8. Geppert TD, Lipsky PE. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3: regulatory influences of monoclonal antibodies to additional T cell surface determinants. J Clin Invest 1988;81: 1497-505.
9. Kozak RW, Moody CE, Staiano-Coico L, Weksler ME. Lymphocyte transformation induced by autologous cells. XII. Quantitative and qualitative differences between human autologous and allogencic reactive T lymphocytes. J Immunol 1982;128:1723-7.
10. Noguchi M, Yi H, Roscnblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147-57.
11. Puck JM, Deschenes SM, Porter JC, et al. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDXI. Hum Mol Genet 1993;2:1099-104.
12. Conley ME, Lavoie A, Briggs C, Brown P, Guerra C, Puck JM, Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci U S A 1988;85:3090-4.
13. Hendriks RW, Chen ZY, Hinds H, Schuurman RK, Craig IW. Carrier detection in X-linked immunodeficiencies. I. A PCR-bascd X chromosome inactivation assay at the MAOA locus. Immunodeficiency 1993;4: 209-11.
14. Puck JM, Krauss CM, Puck SM, Buckley RH, Conlcy ME. Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis. N Engl J Med 1990; 322:1063-6.
15. Buckley RH, Schiff SE, Schiff RI, et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 1993;30:Suppl 4:92-101.
16. O'Reilly RJ, Keever C, Kernan NA, et al. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease. Transplant Proc 1987;19:Suppl 7:55-60.
17. Fischer A, Landais P, Friedrich W, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994;83: 1149-54.
18. Fischer A. Primary immunodeficiencies: molecular aspects and treatment. Bone Marrow Transplant 1992;9:Suppl 1:39-43.
19. Hinds H, Craig IW, Chen ZY, Kraakman ME, Schuurman RK, Hendriks RW. Carrier detection in X-linked immunodeficiencies. II. An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus. Immunodeficiency 1993;4:213-5.
20. Haynes BF, Martin ME, Kay HH, Kurtzberg J. Early events in human T cell ontogeny: phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med 1988; 168:1061-80. [Erratum, J Exp Med 1989;169:603.]
21. Royo C, Touraine JL, de Bouteiller O. Ontogeny of T lymphocyte differentiation in the human fetus: acquisition of phenotype and functions. Thymus 1987;10:57-73.
22. Tavassoli M. Embryonic and fetal hemopoiesis: an overview. Blood Cells 1991;17:269-81.
23. Metcalf D, Moore MAS. Embryonic aspects of haemopoiesis. In: Neuberger A, Tatum EL, eds. Haemopoietic cells. Vol. 24. Amsterdam: North-Holland, 1971;172-271.
24. Flake AW, Harrison MR, Adzick NS, Zanjani ED. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 1986;233:776-8.
25. Fleischman RA, Mintz B. Prevention of genetic anemias in mice by microinjection of normal hematopoietic stem cells into the fetal placenta. Proc Natl Acad Sci USA 1979;76:5736-40.
26. Pallavicini MG, Flake AW, Madden D, et al. Hemopoietic chimerism in rodents transplanted in utero with fetal human hemopoietic cells. Transplant Proc 1992;24:542-3.
27. Zanjani ED, Pallavicini MG, Ascensao JL, et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 1992;89:1178-88.
28. Flake AW, Zanjani ED. In utero transplantation of hematopoietic stem cells. Crit Rev Oncol Hematol 1993;15:35-48.
29. Touraine JL, Roncarolo MG, Bacchetta R, et al. Fetal liver transplantation: biology and clinical results. Bone Marrow Transplant 1993;11:Suppl 1:119-22.
30. Touraine JL, Raudrant D, Royo C, et al. In-utero transplantation of stem cells in bare lymphocyte syndrome. Lancet 1989;1:1382.
31. Touraine JL. In utero transplantation of stem cells in humans. Nouv Rev Fr Hematol 1990;32:441-4.
32. Idem. Stem cell transplantation in primary immunodeficiency, with special reference to the first prenatal, in utero, transplants. Allergol Immunopathol (Madr) 1991;19:49-51.
33. Zanjani ED, Lim G, McGlave PB, et al. Adult haematopoietic cells transplanted to sheep fetuses continue to produce adult globins. Nature 1982;295:244-6.
34. Crombleholme TM, Harrison MR, Zanjani ED. In utero transplantation of hematopoietic stem cells in sheep: the role of T cells in engraftment and graft-versus-host disease. J Pediatr Surg 1990;25:885-92.
35. Zanjani ED, Flake AW, Rice HE, Hedrick M, Tavassoli M. An in vivo comparison of potential human donor hematopoietic stem cell (HSC) sources for bone marrow transplantation using the human/sheep xenograft model. Blood 1993;82:Suppl:655a. abstract.
36. Srour EF, Zanjani ED, Brandt JE, et al. Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood 1992;79:1404-12.
37. Srour EF, Zanjani ED, Cornetta K, et al. Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 1993;82:3333-42.
38. Civin CI, Lee MJ, Hedrick M, Rice H, Zanjani ED. Purified CD34+/ lineage/38 - cells contain hematopoietic stem cells. Blood 1993;82:Suppl: 180a. abstract.
39. Shulman LP, Elias S. Amniocentesis and chorionic villus sampling. West J Med 1993;159:260-8.
40. Moise KJ Jr. Intrauterine transfusion with red cells and platelets. West J Med 1993;159:318-24.
41. Tjonnfjord GE, Steen R, Veiby OP, Friedrich W, Egeland T. Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T lymphocyte reconstitution after bone marrow transplantation for B-SCID. Blood 1994;84:3584-9.